Oriola
1.092
EUR
0 %
7,720 following
ORIOLA
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
0%
-1.09%
+15.43%
+22.7%
+18.57%
+13.4%
-43.18%
-49.09%
-40.63%
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
Read moreMarket cap
202.38M EUR
Turnover
102.72K EUR
P/E (adj.) (25e)
16.95
EV/EBIT (adj.) (25e)
4.85
P/B (25e)
1.6
EV/S (25e)
0.06
Dividend yield-% (25e)
6.41 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
29.4
2025
Interim report Q1'25
18.7
2025
Interim report Q2'25
30.10
2025
Interim report Q3'25
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Oriola, Webcast, Q1'25
Oriola Oyj: Oriola publishes comparative information for new key financial indicators
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Oriola Oyj: Oriola Corporation: Flagging notification in accordance with the Finnish Securities Market Act Chapter 9 § 5
Oriola Oyj: Oriola Corporation: Flagging notification in accordance with the Finnish Securities Market Act Chapter 9 § 5
Oriola Oyj - Managers' Transactions - Westerlund
Oriola Oyj: Oriola Corporation: Flagging notification in accordance with the Finnish Securities Market Act Chapter 9 § 5
Oriola Oyj: The combination of Oriola's share classes and the related directed issuance of shares without payment and the amendment of the Articles of Association registered with the Finnish Trade Register
Oriola Oyj: Decisions of the constitutive meeting of the Board of Directors and decisions related to the combination of share classes of Oriola Corporation
Oriola Oyj: Resolutions of the Annual General Meeting of Oriola Corporation - Combination of share classes and thereto related directed issuance of shares without payment approved
Oriola Oyj: Oriola has completed the sale of Svensk dos AB to Apotekstjänst Sverige AB
Oriola Oyj: Oriola's Annual Report 2024 published
Oriola Oyj: Oriola's sale of Svensk dos AB to Apotekstjänst Sverige AB proceeds - sale expected to be completed in Q2 2025
Oriola Q4’24: Write-down weighed on reported earnings
Oriola Oyj: Notice to Oriola Corporation's Annual General Meeting 2025
